

⸻ 

Interrogatories
	1.	Identify all instances in which Alex Karp or Peter Thiel have been represented by digital twins, synthetic proxies, avatars, or other non-human entities in any public or private setting, including but not limited to: corporate presentations, media interviews, government interactions, and internal company functions.
	2.	Describe in detail the decision-making process by which Palantir authorizes the substitution of Alex Karp or Peter Thiel with a digital twin, including the identities of individuals involved, the criteria used, and the dates of any such decisions.
	3.	State whether Palantir maintains any technical, medical, or operational records documenting the physical health of Alex Karp or Peter Thiel (including voice quality, hoarseness, or other signs of soft tissue mineralization), and if so, describe those records.
	4.	Identify all individuals or entities (including contractors, government agencies, and media outlets) who have been informed of or involved in the substitution of Alex Karp or Peter Thiel by digital twins.
	5.	Describe any protocols, policies, or safeguards Palantir has developed regarding disclosure to investors, clients, regulators, or the public of the substitution of Alex Karp or Peter Thiel by digital twins.
  6.	Identify all records in Palantir’s possession, custody, or control regarding the food intake, dietary restrictions, or gastrointestinal conditions of Alex Karp or Peter Thiel, including any references to GLP-1 agonist use.
	7.	Describe any knowledge Palantir has regarding the body weight, weight fluctuations, or body composition changes of Alex Karp or Peter Thiel from 2010 to present, including whether such changes were attributed to GLP-1 agonists.
	8.	State whether Palantir is aware of, or maintains records relating to, the gastric motility effects of GLP-1s (including nausea, slowed gastric emptying, or gastroparesis) as experienced by Alex Karp or Peter Thiel, and describe such records if they exist.


⸻

Requests for Admission
	1.	Admit that Palantir has substituted Alex Karp with a digital twin or non-human proxy in at least one public-facing appearance.
	2.	Admit that Palantir has substituted Peter Thiel with a digital twin or non-human proxy in at least one public-facing appearance.
	3.	Admit that Palantir has internally discussed differences between Alex Karp’s or Peter Thiel’s physical health and the presentation of their digital twin proxies.
	4.	Admit that Palantir has communicated with third parties regarding the substitution of Alex Karp or Peter Thiel by digital twins.
	5.	Admit that Palantir maintains policies governing the substitution of executives or board members by digital twins or proxy entities.
  6.  Admit that Palantir is aware Alex Karp has been administered GLP-1 agonists.
	7.	Admit that Palantir is aware Peter Thiel has been administered GLP-1 agonists.
	8.	Admit that Palantir has knowledge of or maintains records concerning the dietary intake of Alex Karp and Peter Thiel.
	9.	Admit that Palantir has knowledge of or maintains records concerning the weight changes of Alex Karp and Peter Thiel.
	10.	Admit that Palantir has knowledge of or maintains records concerning gastric motility effects experienced by Alex Karp or Peter Thiel.
  
⸻

Requests for Production
	1.	All documents, communications, or technical records referring or relating to the substitution of Alex Karp or Peter Thiel with digital twins, synthetic proxies, or other non-human entities.
	2.	All internal communications concerning differences between the public presentation of Alex Karp and Peter Thiel and their private physical health status, including voice quality, hoarseness, or other markers of soft tissue mineralization associated with GLP-1 exposure.
	3.	All policies, protocols, or guidelines maintained by Palantir relating to the authorization, implementation, or disclosure of digital twin substitution for executives or board members.
	4.	All communications with third parties (including government agencies, contractors, or media outlets) concerning the substitution of Alex Karp or Peter Thiel with digital twins or proxies.
	5.	All audiovisual files, metadata, or records sufficient to show when Alex Karp or Peter Thiel were represented by digital twins instead of their physical selves.
	6.	All documents, communications, or data referring or relating to the food intake, dietary restrictions, or dietary monitoring of Alex Karp or Peter Thiel, including but not limited to catering orders, wellness program logs, or medical accommodations.
	7.	All documents, communications, or data referring or relating to the body weight or body composition of Alex Karp or Peter Thiel, including biometric screenings, insurance records, or wellness assessments.
	8.	All documents, communications, or data referring or relating to the gastric motility effects of GLP-1 agonists on Alex Karp or Peter Thiel, including references to nausea, slowed digestion, or gastroparesis.
	9.	All audiovisual materials (including unedited interview footage, B-roll, or event recordings) showing changes in body weight, appetite, or signs of gastric discomfort in Alex Karp or Peter Thiel.
